문서의 이전 판입니다!
자궁내막 증식증 (Endometrial Hyperplasia)
원인
Endometrial hyperplasia almost always results from excess estrogen exposure. This may be caused by obesity, anovulation, estrogen therapy without a progestin, or estrogen producing ovarian tumors
경과
Type | progression to cancer (%) |
---|---|
Simple (cystic without atypia) | 1 |
Complex (adenomatous without atypia) | 3 |
Simple (cystic with atypia) | 8 |
Complex (adenomatous with atypia) | 29 |
[Ref]1)
Treatment
Medroxyprogesterone acetate | 10–20 mg daily or cyclic 12–14 d/mo |
Depot medroxyprogesterone | 150 mg intramuscularly every 3 mo |
Micronized vaginal progesterone | 100–200 mg daily or cyclic 12–14 d/mo |
Megestrol acetate | 40–200 mg per d, usually reserved for women with atypical hyperplasia |
Levonorgestrel-containing intrauterine device | 1–5 y |
without atypia
- Cyclical progestin therapy: medroxyprogesterone acetate, 10-20 mg/day for 14 days per month
- Continuous progestin therapy: megestrol acetate, 20-40 mg/day
With atypia
- Continuous progestin therapy: megestrol acetate (40-160 mg/day)
- For women with atypical complex hyperplasia who no longer desire fertility, hysterectomy is recommended.
- 메게시아 Megestrol Acetate 40mg / 1 tablet /246원
내막증이 있다고 판단되면 이 듀파스톤이 자궁내막의 증식을 억제하므로 복용하셔도 되고 또 다른 황체호르몬제도 있어서 다른 약을 복용하셔도 된다. 자궁내막증을 치료하기 위해 듀파스톤이란 프로게스테론 제제를 먹고 있는바 이는 자궁내막의 증식을 막고 배란도 억제 한다.
F/U
- Therapy should be continued for 2 to 3 months, and endometrial biopsy should be performed 3 to 4 weeks after completion of therapy to assess response.
- Periodic endometrial biopsy or transvaginal ultrasonography d/t undiagnosed cancer in 25% of cases, progression rate to cancer
1)
The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients.
AUKurman RJ, Kaminski PF, Norris HJ
SOCancer. 1985;56(2):403.